Finance

Beta
Lists
PANACEABIO:NSE
Panacea Biotec Ltd
₹539.80
+3.35%
(+17.50) 1D
Jun 12, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for PANACEABIO...
Open
₹535.00
High
₹544.40
Low
₹522.60
Mkt. cap
32.70B
Avg. vol.
1.28M
Volume
368.28K
52-wk high
₹647.00
52-wk low
₹292.40
EPS
-₹0.88
Shares outstanding
61.25M
No. of employees
2K
Open
₹535.00
High
₹544.40
Low
₹522.60
Mkt. cap
32.70B
Avg. vol.
1.28M
Volume
368.28K
52-wk high
₹647.00
52-wk low
₹292.40
EPS
-₹0.88
Shares outstanding
61.25M
No. of employees
2K
News stories
From sources across the web
Profile
Panacea Biotec is a global generic and specialty pharmaceutical and vaccine maker. It has principal offices in New Delhi, Mumbai, and Lalru. It has business interests in research, development, manufacturing and marketing of pharmaceutical formulations, vaccines, biosimilars, and natural products. Wikipedia
About Panacea Biotec Ltd
CEO-
Employees2.15K
Founded1984
Headquarters-
SectorBiotechnology
Websitepanaceabiotec.com
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.67B
1.41B
1.65B
1.67B
Cost of goods sold
772.20M
589.40M
679.30M
763.90M
Cost of revenue
772.20M
589.40M
679.30M
763.90M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
457.20M
477.10M
405.30M
468.20M
Operating expense
990.50M
1.08B
939.70M
956.70M
Total operating expenses
1.76B
1.67B
1.62B
1.72B
Operating income
-95.70M
-261.30M
32.90M
-53.10M
Other non operating income
56.70M
64.00M
22.80M
25.50M
EBT including unusual items
65.60M
-191.70M
64.90M
-12.50M
EBT excluding unusual items
-47.60M
-218.70M
37.20M
-39.60M
Income tax expense
26.00M
-51.60M
26.00M
-2.50M
Effective tax rate
39.63%
26.92%
40.06%
20.00%
Other operating expenses
449.40M
522.70M
449.90M
409.70M
Net income
40.50M
-139.20M
39.80M
5.20M
Net profit margin
2.43%
-9.86%
2.41%
0.31%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-8.60M
-21.40M
-18.50M
-12.00M
Net interest expenses
-8.60M
-21.40M
-18.50M
-12.00M
Depreciation and amortization charges
83.90M
83.40M
84.50M
78.80M
EBITDA
-8.68M
-177.60M
113.44M
29.55M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer